Understanding pancreatic cancer through a systems metabolic approach
Official title: Systems Metabolic Approach for Multi-scale Pancreatic Cancer Phenotyping
Funded at University of California Los Angeles · NIH-10946197 · Data updated 2026-11-12
This study is looking at pancreatic cancer by using different tests and methods to get a clearer picture of how the disease works, and it’s inviting patients to help by sharing samples or information that could lead to better treatments.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $622,984 |
| NIH project number | 1R37CA292781-01 |
| Project ID | NIH-10946197 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with pancreatic adenocarcinoma or those at high risk for developing the disease.
✕Less likely to help
Patients with non-cancerous pancreatic conditions or those who do not have pancreatic cancer may not benefit from this research.
What this research studies
This research investigates pancreatic cancer by integrating various diagnostic methods to better understand how the disease develops and spreads. It aims to combine insights from genetic mutations, imaging techniques, and tissue analysis to create a comprehensive picture of pancreatic cancer phenotypes. By linking measurements from different disciplines, the research seeks to identify consistent characteristics of the disease across multiple levels, which could lead to improved treatment strategies. Patients may be involved in providing samples or data that contribute to this integrative approach.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and better outcomes for patients with pancreatic cancer.
How similar studies have gone: Other research has shown promise in integrating multi-modal approaches to cancer characterization, suggesting potential for success in this novel approach.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Jamshidi, Neema — University of California Los Angeles
- Study coordinator: Jamshidi, Neema
Related research
Other NIH-funded projects on the same topics.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Targeting aberrant enhancer landscapes in pancreatic cancer
A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.
-
Exosome-based microRNA biomarkers for early, non-invasive detection of pancreatic cancer
A study to develop a blood test that uses tiny RNA signals in exosomes to detect pancreatic cancer early, aiming to help people at risk or with early disease.
-
Exosome-based microRNA biomarkers for early detection of pancreatic cancer
A patient-friendly look at a study using tiny blood-based RNA markers inside exosomes to catch pancreatic cancer early without invasive procedures.
-
Programmable implanted living materials to fight pancreatic cancer
A patient-facing program will explore a safe, implantable living material that delivers sequential immunotherapies directly to pancreatic tumors to help fight cancer.
-
Targeting how platelets and pancreatic cancer talk to each other
A study exploring whether blocking the interaction between platelets and pancreatic cancer cells could slow cancer growth and spread and help identify new biomarkers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.